Further bone-derived soluble factors cooperate with tumor-derived laminin 511, an adhesive and pro-migratory substrate for tumor cells, to facilitate migration and invasion of bone-metastatic breast cancer cells via an upregulation of the AKT signaling and MMP9. Here, MMP9 is linked to breast carcinoma.